Resona Asset Management Co. Ltd. Buys New Holdings in Aflac Incorporated (NYSE:AFL)

Resona Asset Management Co. Ltd. purchased a new stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 172,522 shares of the financial services provider's stock, valued at approximately $17,843,000.

A number of other large investors have also recently modified their holdings of the business. Whipplewood Advisors LLC bought a new stake in Aflac during the fourth quarter valued at approximately $26,000. BankPlus Trust Department purchased a new stake in shares of Aflac during the 4th quarter valued at $34,000. Raelipskie Partnership bought a new stake in shares of Aflac during the 3rd quarter worth $38,000. Curio Wealth LLC purchased a new position in Aflac in the fourth quarter worth $36,000. Finally, OFI Invest Asset Management bought a new position in Aflac in the fourth quarter valued at $38,000. Institutional investors own 67.44% of the company's stock.

Insider Activity

In other Aflac news, Director Charles D. Lake II sold 29,802 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

Remove Ads

Aflac Stock Up 0.7 %

AFL stock traded up $0.73 during midday trading on Friday, hitting $105.41. The company's stock had a trading volume of 471,065 shares, compared to its average volume of 2,147,446. The company has a market cap of $57.53 billion, a PE ratio of 10.97, a P/E/G ratio of 3.24 and a beta of 0.81. The firm's 50-day moving average is $106.34 and its 200-day moving average is $107.44. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, equities research analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on AFL shares. UBS Group upped their price objective on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. increased their price target on shares of Aflac from $94.00 to $96.00 and gave the company a "neutral" rating in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods lowered their price objective on shares of Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a report on Wednesday, February 12th. Piper Sandler boosted their target price on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Finally, BMO Capital Markets started coverage on shares of Aflac in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $103.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.